UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 12b-25

 

Commi ssion File Number: 00 0 - 51772

CUSIP Number: 252366109

 

NOTIFICATION OF LATE FILING

 

(Check One) : ☒ Form 10-K   ☐ Form 20-F   ☐ Form 11-K   ☐ Form 10-Q   ☐ Form 10-D   ☐ Form N-SAR   ☐ Form N-CSR

 

For Period Ended:     June 30 , 2016                                                   

 

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

☐ Transition Report on Form N-SAR

☐ For the Transition Period Ended:                                                 

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 
 

PART I -- REGISTRANT INFORMATION

 

Dextera Surgical Inc.

Full Name of Registrant

 

N/A

Former Name if Applicable

 

900 Saginaw Drive

Address of Principal Executive Office (Street and Number)

 

Redwood City, CA 94 063

City, State and Zip Code

 

PART II -- RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the Registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

 

    (a)

The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

       

 

☒

  (b)

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

       
    (c)

The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

 
 

 

PART III -- NARRATIVE

 

State below in reasonable detail why the Form s 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR or the transition report portion thereof could not be filed within the prescribed time period.

 

Dextera Surgical Inc. expects to submit the Annual Report on Form 10-K (the “Form 10-K”) for the year ended June 30, 2017, on or before October 13, 2017. Dextera Surgical was unable to file the 10-K within the prescribed time period without unreasonable effort or expense because additional time is required by the Registrant to provide certain information and documentation to complete the financial statements in the Form 10-K, causing the Registrant to be delayed in its filing of the Form 10-K.

 

PART IV-- OTHER INFORMATION

 

(1)

Name and telephone number of person to contact in regard to this notification

 

  Robert Y. Newell   650   331-7133  
 

(Name)

 

(Area Code)

 

(Telephone Number)

 

           

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).   
  Yes ☒     No ☐                        
   
   

(3)

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

 
Yes ☐     No ☒                       
   
  If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
   
   

 

 

Dextera Surgical Inc.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date : September 29 , 201 7                                      

By:

/s/  Robert Y. Newell

 

 

 

Name: Robert Y. Newell

 

 

 

Title: Chief Financial Officer

 

   

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.

 

ATTENTION

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).